DJIA 17,186.17 211.86 1.25%
NASDAQ 4,568.10 18.87 0.41%
S&P 500 1,996.09 13.79 0.70%
market minute promo

193.80 3.31 (1.74%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

ALXN $193.80 1.74%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $190.21
Previous Close $190.49
Daily Range $189.15 - $193.79
52-Week Range $113.14 - $193.90
Market Cap $38.4B
P/E Ratio 79.37
Dividend (Yield) $0.00 (0.0%)
Volume 681,214
Average Daily Volume 1,407,396
Current FY EPS $4.72

Sector

Healthcare

Industry

Drugs

Alexion Pharmaceuticals, Inc. (ALXN) Description

A biotechnology company working to develop and deliver life-changing drug therapies for patients with serious and life-threatening medical conditions. Website: http://www.alexionpharm.com/

News & Commentary

The 5 Most Expensive Drugs in the World

The five most expensive drugs in the world from 2013 will set you back a minimum of $205,000 per year. Find out what makes these drugs so special -- and why they carry such exorbitant price tags.

Biotech Stock Roundup: Beat & Raise Quarter for Amgen, Celgene, Alexion, Biogen - Analyst Blog

Biotech Short Interest Becomes Stock Specific

Company News for October 24, 2014 - Corporate Summary

Alexion Pharmaceuticals (ALXN) Earnings Report: Q3 2014 Conference Call Transcript

Alexion Beats on Earnings & Revenues in Q3, Guides Up - Analyst Blog

Researchers to Present Data on Soliris As A Treatment For Patients With aHUS At ASN 2014 Annual Meet

Researchers to Present Data on Soliris As A Treatment For Patients With aHUS At ASN 2014 Annual Meeting

Alexion Pharmaceuticals (ALXN) Q3 2014 Results - Earnings Call Webcast

Will Alexion (ALXN) Earnings Suffer Due to Higher Costs? - Analyst Blog

End Of The Year Events To Drive Some Of October's Beaten Up Biotech Companies

See More ALXN News...

ALXN's Top Competitors

ALXN $193.80 (1.74%)
Current stock: ALXN
AMGN $161.09 (1.39%)
Current stock: AMGN
GILD $114.21 (3.15%)
Current stock: GILD
BIIB $322.99 (2.52%)
Current stock: BIIB